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Abstract
Introduction: Australia is an ageing multicultural society with an increased prevalence of chronic conditions. The rise of 
coexisting diabetes, kidney disease and hypertension is placing a significant and increasing demand on Australian health services. 
Prescribed medications are a key component of reducing the disease burden of these coexisting conditions, and successful 
treatment is largely dependent on self-management of medications. Culturally and linguistically diverse (CALD) groups have an 
increased risk of medication mismanagement and are often excluded from intervention studies. We examined an intervention in 
this group and report on some of the difficulties and resource issues involved with studying CALD groups.
Methods: Patients aged ≥18 years of age with chronic kidney disease, diabetes and cardiovascular disease whose preference it 
was to speak Greek, Italian or Vietnamese were recruited from nephrology outpatients’ clinics of two Australian metropolitan 
hospitals in 2009. A translated, multifactorial intervention, consisting of a medication review, a short PowerPoint presentation 
and motivational interviewing designed to improve medication self-efficacy and adherence, was tested in a randomised 
controlled trial (RCT) with 12 months follow-up post-baseline. People collecting data and assessing outcomes were blinded to 
group assignment.
Results: Seventy-eight participants were recruited and 29 participants completed the study. There were no significant 
differences in medication self-efficacy or adherence between the intervention and control groups at three, six and 12 months 
post-baseline.
Conclusion: The pilot study was not feasible due to high attrition rates. This work has highlighted difficulties with conducting 
research into CALD groups using interpreting services and health literacy issues affecting medicine self-management in this 
group.
Trial registration: The trial was prospectively registered with the Australian and New Zealand Clinical Trials Register 
(ACTRN126080000313336).
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Introduction
Combinations of chronic and synergistic conditions such as 
chronic kidney disease (CKD), diabetes and cardiovascular 
disease (CVD) have attracted attention in recent years because 
of increased morbidity and burden on health care services 
beyond the sum of each disease (Tong & Stevenson, 2007). 
The importance of managing coexisting diseases is critical to 
prevent downstream mortality and morbidity as well as the risk 
of duplicated, incompatible or conflicting treatments that can 
negatively affect health outcomes (Bakris et al., 2004).
Prescribed medications are a key component of chronic illness 
self-management and their effectiveness depends on the person’s 
adherence to treatment and self-efficacy – the confidence 
or ability to feel “I can do that” (Sabaté, 2003). Adherence is 
defined as the extent to which people follow the instructions 
they are given for prescribed treatments (Haynes et al., 2008). 
However, the presence of multiple chronic conditions, multiple 
prescribers, frequent changes to medication regimens and 
higher medication doses increase a person’s risk of medication 
mismanagement and nonadherence (Johnson et al., 2005). This 
risk is significantly increased in culturally and linguistically 
diverse (CALD) groups (Lorig et al., 2005; Walker et al., 2005).
Although pharmaceutical developments in disease management 
are extensive, strategies to assist people to accurately follow 
medication prescriptions for chronic conditions are needed 
(Haynes et al., 2008). Overall medication-related morbidity 
accounts for 4.3% of preventable hospital admissions worldwide 
(Winterstein et al., 2003). Research into medication self-
management has rarely focused on medications for long-term, 
multiple diseases in CALD groups, and CALD groups are 
often excluded from intervention studies. Australia embraces a 
multicultural society where up to a quarter of Australians may 
have limited health literacy which is higher in older, non-
English speaking people (Barber et al., 2009).
A pilot study on medication adherence in CALD consumers 
with CKD, diabetes and hypertension demonstrated consumers 
did not know what all their medications were for or how they 
helped to control disease progression (Williams et al., 2008). In 
addition, consumers demonstrated a lack of clarity about drug 
doses, the interrelationship of the diseases, or where to seek 
help about their medications. A systematic review that evaluated 
the effect of interventions to improve medication adherence 
in people of CALD backgrounds found that relatively little 
work has been conducted in this area (Manias & Williams, 
2010). Six studies showed statistically significant improvements 
in medication adherence, of which three were randomised 
controlled trials (RCTs). Successful interventions involved 
delivery by a bilingual person or the use of translated materials. 
The aim of this pilot study was to test the feasibility and impact 
of a multi-factorial Self-Efficacy Medication (SEM) intervention 
to improve medication self-efficacy and adherence for CALD 
consumers with CKD, diabetes and CVD.
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Method
The study was a double-site, single-blind, longitudinal RCT 
conducted in Melbourne, Australia.
Participants
Participants were recruited from nephrology outpatient clinics at 
two public tertiary metropolitan hospitals providing health care 
to a population wherein approximately 40% of patients speak 
languages other than English at home, most commonly Greek, 
Italian or Vietnamese. Participants were randomly allocated to 
one of two groups: a multifactorial intervention designed to 
improve medication self-efficacy and adherence, and a control 
group who received “standard care” through outpatient clinics 
and primary care. Blood pressure control was an important 
aspect of standard care which was dependent on the patient’s 
individual circumstances and morbidity. Details of standard care 
have been reported elsewhere (Williams et al., 2010).
The SEM intervention was tested on consumers who met the 
following inclusion criteria: non-English speaking background; 
preference to speak Greek, Italian or Vietnamese at home; of 
either gender; aged ≥ 18 years; the combined diagnoses of 
Stages 2–4 CKD (diagnosed by eGFR>15 and ≤ 60); Type 1 or 
2 diabetes, and evidence of CVD (hypertension, heart failure, 
hyperlipidaemia) in the medical record, requiring routine 
outpatient specialist clinic appointments at the two nephrology 
outpatient clinics. Patients were excluded if they lived more 
than 50 kilometres from the participating hospitals to enable 
the study to be conducted within the allocated budget. Other 
exclusion criteria included pregnancy and a diagnosis of cancer 
within the past six months prior to enrolment in the study.
Recruitment
Patients were recruited at the clinic by the research assistant 
with the assistance of a hospital interpreter or English-speaking 
relatives who accompanied the patient for the consultation. In 
this situation, a copy of the plain language statement (patient 
information sheet) was given to the family to explain the study 
to the potential participant. 
The research assistant then contacted the potential participant 
to organise a home visit with those who verbally agreed to 
participate using interpreter services to talk through the plain 
language statement prior to obtaining informed consent. 
Recruitment at the participating hospitals’ outpatient renal 
clinics commenced in February 2009 and closed in mid-June 
2009.
Conceptual framework
The modified Health Belief Model (HBM) (Becker, 1976; 
Rosenstock, 1974) was used as the conceptual framework to 
underpin this study. This model assumes that people will follow 
prescribed treatments if they believe that doing so will avoid 
negative health outcomes and they have the self-efficacy to 
do it. People’s “readiness to act” is dependent on perceived 
susceptibility to a particular health problem, the severity of 
the health problem, the benefits and barriers to taking positive 
health-related action, and self-efficacy (Glanz et al., 2002).
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The intervention
Previous literature and analysis of pilot interviews conducted 
by the project team were used to develop a multifactorial 
intervention consisting of an individualised medication review, a 
20-minute PowerPoint presentation, and fortnightly follow-up 
telephone motivational interviewing for 12 weeks to support 
optimal medication self-management. The intervention was 
originally developed for English-speaking participants and 
the protocol has been reported elsewhere (Williams, Manias, 
Walker, 2010). The presentation was translated into Greek, 
Italian and Vietnamese by independent graduate interpreters. It 
was planned that the presentation would be a DVD translated 
into the three languages but the cost of imputing each letter 
of the translation into each language was prohibitive. Some of 
the original health-related terminology was modified to ensure 
cultural sensitivity. All aspects of the intervention were led by 
the intervention nurse who took field notes and adhered to the 
protocol to ensure a consistent approach to the delivery of the 
intervention and for fidelity purposes.
Each participant received an individual medication review 
session from the intervention nurse. The individualised 
medication review involved the intervention nurse drawing up a 
chart of the participant’s prescribed medications as documented 
by the research assistant at the enrolment visit (Time 1), which 
included the generic and brand name of the medication, what 
the medication was for, the dose and when to take it, and targets 
for which to aim, for example, systolic blood pressure ≤130 
mmHg and Hb A1C < 7% (a measure of diabetes control) as 
recommended by Harris (2009). Prescription reconciliation, 
the process of comparing the participant’s reported medication 
regimen to all of the medications that the participant had 
been taking, was conducted. Any areas of ambiguity with what 
participants thought they should be taking compared with what 
was prescribed according to pill containers and medication lists 
were clarified. The interpreter wrote on medication boxes in the 
participant’s language or used symbols to reinforce what their 
medications were for. The medication chart written in English 
was left with the participants as their personal medication record 
to take to medical consultations.
The PowerPoint presentation took a psychosocial approach 
and comprised three themes: how blood pressure affects the 
body, the needs, benefits and safety of prescribed medications 
and strategies to enhance medication self-efficacy. Video clips 
of positive medication adherence role modelling exemplars 
by consumers with CKD, diabetes and CVD obtained in 
the pilot study were incorporated into the presentation. 
Combining information with consumer-led advice is likely to 
improve chronic disease self-management and forms the basis 
of many global self-help organisations (Murray et al., 2006). 
The interpreter spoke to the presentation in the participant’s 
first language and the intervention nurse clarified any areas 
of uncertainty which was translated back to the participant. 
In some instances, English-speaking relatives assisted with 
interpretation. The translated PowerPoint presentation in the 
form of a booklet was given to the consumer to review and an 
English language version of the PowerPoint in the form of a 
DVD was left for interested English-speaking relatives to view.
Fortnightly follow-up telephone calls conducted by the 
intervention nurse with an interpreter to support optimal 
medication self-management were conducted following the 
intervention home visit for 12 weeks. Each call was conducted 
using the principles of motivational interviewing to promote 
optimal medication self-management, adapted from the 
guidelines of Dilorio et al. (2003). The participants’ self-reported 
motivation and confidence in taking their medications was 
scored out of 1 to 10, using this information to elicit barriers, 
concerns and positive self-motivational statements.
Sample size
The sample size was derived from the Medication Adherence 
Self-efficacy Scale (Ogedegbe et al., 2003) involving self-
efficacy scores ranging from 1 to 3, with higher values being 
more desirable. Past work showed a mean of 2.48±0.5 with a 
clinically relevant effect size at 13% (mean of 2.8), indicating 52 
consumers in each group, using an alpha level of .05 and a beta 
level of 0.2 (power of 90%). Attrition of 10% was accounted for, 
totalling 57 in each group.
Randomisation
Participants were allocated code numbers prior to 
randomisation. The study population was stratified according 
to the three ethnic groups and automatically randomised 1:1 
according to age and gender within each group using a purpose-
built randomisation sequence computer program. The identity 
of all participants and those who were randomised to receive 
the intervention were kept on the chief researcher’s computer 
in a locked office at the university. The research assistant and 
interpreters who collected data and the statistician were blinded 
to the intervention group. The interpreters were blinded to 
the intervention group. Participants in the intervention group 
could not be blinded and were asked to not disclose their group 
allocation to the research assistant or interpreter during data 
collection.
Data collection
Participants were surveyed at baseline, immediately post-
intervention, three months post-intervention and nine months 
post-intervention (12 months post-baseline) by the research 
assistant with interpreter assistance. Data were collected from the 
control group at the same time points as the intervention group.
Instruments
1. The Abbreviated Mental Health Score test (Hodkinson, 1972) 
comprises 10 questions, and a score <6 indicates dementia and 
the patient was excluded from the study.
2. The 26-item Medication Adherence Self-efficacy Scale 
(MASES) (Ogedegbe et al., 2003) has a Likert scale with three 
possible responses, and scores range from 26 to 78. It has a 
Cronbach’s α coefficient of 0.95.
3. The four-item Morisky medicine adherence scale (Morisky et 
al., 1986) has a Cronbach’s α coefficient of 0.62, “yes” and “no” 
answers, with a score of 0 representing complete adherence.
Secondary outcome measures included the SF-12v2-Item 
Health Survey (Ware et al., 1996). Cronbach’s α coefficients 
closely mirror that of the SF-36 at 0.89 and 0.76, with a 
relative validity of 0.67. Health care use was surveyed using 
Lorig et al.’s (1996) four-question health care utilisation scale 
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that has a test-retest reliability of 0.91. Lower scores indicate 
less health care use. Routine clinical laboratory surrogate 
measures which included eGFR, serum creatinine, and Hb A
1C
, 
indicative of good medication self-management taken as part 
of the participant’s standard treatment were collected from the 
participant’s medical records.
Ethics and registration
Prior to commencing the study, ethics approval was sought 
and granted from the ethics in human research committees 
of the participating hospitals (HREC Project No: 2006.239 
and HREC-A061/08) and university (Ethics ID: 0713622). 
The interpreter or family member spoke to the plain language 
statement and participants’ queries were answered with the 
assistance of the intervention nurse prior to signing the 
informed consent. The trial was prospectively registered with 
the Australian and New Zealand Clinical Trials Register before 
recruitment of the first participant (Registration number 
ACTRN126080000313336). The study was conducted 
according to the protocol and under ethical guidelines of the 
National Health and Medical Research Council of Australia 
(2007).
Data analysis
The study’s feasibility was assessed by attrition rates, the 
intervention group’s participation in all aspects of the 
intervention, and a single, open-ended question asking if the 
programme was useful on its completion. Descriptive statistics 
were conducted using the Statistical Package for the Social 
Sciences (SPSS), version 17.0 (SPSS Inc., Chicago IL) including 
frequencies for categorical variables and means and standard 
deviations for continuous variables. Baseline characteristics 
of the intervention and control groups were compared. The 
difference in mean change in self-efficacy and medication 
adherence between groups was determined by unpaired t-tests. 
Continuous variables that were not normally distributed were 
examined using equivalent non-parametric tests. P values less 
than .05 were considered statistically significant. The analysis was 
performed on an intent-to-treat basis. The CONSORT 2010 
guidelines (Moher et al., 2010) were used to prepare this paper.
Results
Figure 1 shows the flow of participants throughout the trial. 
Patients were screened at the hospital renal clinics (Tuesday and 
Wednesday mornings and a monthly Friday at one site, and 
Tuesday afternoons at the second site, excluding three public 
holidays and one cancelled clinic because of a nephrology 
conference). Of the 243 patients screened, 14 declined to 
participate (on the grounds of self-reported “understands 
sufficiently”, “managing well”, “too busy”, “stubborn”, “has too 
many medicines and can’t afford to get too excited”, “having 
trouble finding appropriate medicines”).
Seventy-eight people verbally agreed to participate at the clinics 
(26 Greek, 39 Italian and 13 Vietnamese) before recruitment 
closed. After recruitment closed, the baseline visits (Time 1) 
were organised into blocks according to each language for the 
efficient use of interpreter services. This caused a delay of up 
to three months between recruitment and enrolment at the 
baseline visits for some participants.
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The intervention nurse booked the interpreters to ensure 
that blinding was maintained between the intervention and 
control groups. At the baseline visit (T1), 13 patients withdrew 
agreement to participate (“not interested”, “a waste of time”, 
“doesn’t need it”, specialist takes care of medicines, no 
immediate benefits), of which five patients declined on the 
home visit with the research assistant and interpreter.
A total of 48 patients consented to participate in the study 
and had baseline information collected (Table 1). The majority 
had a support person at home, were retired, owned their own 
homes and had primary school education only. Fourteen 
participants claimed they did not know they had kidney disease 
(evidenced by eGFR tests) even though they had been attending 
a nephrology clinic and two participants claimed to not know 
they had diabetes. In these instances, the researcher confirmed 
with medical staff that the participant did have the specified 
illnesses. At the baseline visit, one Vietnamese participant stated 
he knew he had diabetes but he ignored it as he did not want to 
change his diet.
Table 1. Self-reported details of participants at enrolment (n=48).
Characteristics Statistics
Male gender 30
Age (years), mean (SD) 74.31(8.37)
Married/de facto 39
Country of birth
          Greece 16
          Italy 23
          Vietnam 8
          Other 1 (Egypt but  
Greek 
upbringing)
Years living in Australia, mean (SD) 41.19(11.49)
Speak English not well or not at all 36
Can not see well 29
Can not hear well 12
Years living with diabetes, mean (SD) 18.14(10.28)
Years living with kidney disease, mean (SD) 8.22(10.43)
Number of other chronic conditions, mean (SD) 3.29(2.18)
Number of current medications, mean (SD) 9.23(3.19)
Systolic blood pressure (mmHg), mean (SD)  149.67(22.6)
Diastolic blood pressure (mmHg), mean (SD) 82.58(8.01)
Undertake regular exercise 26
Follow recommended diet well or very well 26
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There were a further 10 participants lost to follow-up before 
Time 2 data collection (three withdrew from the study, for 
example, “don’t call me again – I don’t want to participate”). 
To minimise further elective drop-outs, we sent an explanatory 
letter that was translated into Greek, Italian and Vietnamese 
to the remaining participants to emphasise the importance of 
CALD research and their continuing participation. Final data 
collection using interpreter services was completed on 30 
August 2010.
Demographics
The demographic and medical characteristics of the participants 
(n=48) at enrolment (T1) are shown in Table 1. The Vietnamese 
had spent the least amount of time living in Australia, reflecting 
Australian immigration patterns. Twenty participants had a 
GP of their same cultural background and 16 participants 
requested an interpreter for their consultation. Seven participants 
stated they could understand enough English at their medical 
consultations and five participants took an English-speaking 
person along, and in one case, a daughter took notes. Only one 
participant sought information from their pharmacist and no 
one used the internet. Nearly half of the participants were ex-
smokers or currently smoked. Participants reported consuming a 
mean of 2.05 (SD 4.51) standard alcoholic drinks per week.
In addition to CKD, diabetes and CVD, participants reported 
having other chronic health conditions, which included arthritis, 
gout, hyperthyroidism, glaucoma and asthma. However, some 
participants were not clear about what conditions they had; 
for example, “not sure what they are called” or labelled some 
chronic conditions as “broken buttock”, “eye bleeding” and 
“blood circulation in the legs”. The median Abbreviated Mental 
health score was 8.4 out of 10. No mental health problems, 
such as depression, were reported. Participants took a median of 
nine different prescribed medications (IQR=5). Average blood 
pressure on enrolment taken according to the specifications of 
O’Brien et al. (2003) was 150/83 mmHg.
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Withdrew (n=1), lost 
to followup (n=1), too ill 
(n=1)
 Refused (n=13), too ill (n=6), lost to 
followup (n=6), in another study (n=2), did not meet inclusion criteria 
(n=2), delayed enrolment until recruitment closed (n=1)
 

 Did not have diabetes 
(n=70)  
In ESKD (n=24) 
Did not have CVD (n=11)  
Declined offer to 
participate (n=14) 
Did not attend 
appointment or left early 
(n=27) 
English first language 
(n=12)  
In another study (n=4) 
 Mentally impaired (n=2) 





 (Greek=11, Italian=20, Vietnamese=7)

Figure 1. Flow chart of participants throughout the trial.
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There was an even spread of participants in the Italian and 
Vietnamese intervention and control groups. However, the 
intervention group had higher Hb A
1C
 levels and systolic blood 
pressure, and less social support at home. The Greek participants 
did not have a control group. In one case, a Greek participant 
was advised by his local doctor to discontinue participation as he 
did not appear to be in the intervention group and “it wouldn’t 
make any difference” to the study results.
There were no significant differences in medication self-efficacy 
between the intervention and control groups at each data 
collection time point. There were no significant differences in 
medication adherence at each data collection time point. There 
were no significant differences in secondary outcomes which 
included general wellbeing, health care utilisation and routine 
clinical laboratory surrogate measures at each data collection 
time point.
Qualitative findings
The field notes recorded that participants were appreciative 
of the one-on-one intervention home visit and motivational 
interviewing calls to clarify questions regarding their 
medications and treatment outside a formal medical 
consultation. Participants received all components of the 
intervention and unanimously reported that they found the 
session helpful and enjoyed learning about their conditions 
in their preferred language. Typical comments were, “satisfied 
to hear all this information that I was not aware of before”, 
and “gives me information that helps me manage my health 
conditions”.
The medication review demonstrated participants’ lack of 
knowledge about what their medications were for, medication 
side effects, duplication of medications and pill burden. One 
participant was taking duplicate cholesterol-lowering drugs 
that were the same but had different brand names. Another 
participant was taking the same generic oral hypoglycaemic 
medication with different brand names on alternate days as he 
was not sure if they were the same. One participant had a tool 
box with each compartment filled with multiple medications 
for copious comorbid conditions, and did not know what most 
medications were for, except for the analgesic medications.
Participants commented that medical information was 
usually provided in English, such as medication information 
in pamphlets, on medication boxes and medication lists, and 
participants could not document changes to medications in 
English. Some participants stated they would have liked the plain 
language statement and hard copy of the medication review in 
their preferred language.
An average of four motivational interviewing calls was made to 
each participant and each call ranged from three to 23 minutes. 
The motivation and confidence scores ranged from five to 
10, with a mean of 8.75 and 8.45 respectively. The women 
participants tended to explore psychosocial concerns, such as 
family illness and relationship breakdowns.
Discussion
This pilot study was significantly limited by the high rate of 
attrition following recruitment. The drop-out rate resulted in 
dissimilar characteristics between groups, no control group for 
the Greek cohort, and an unpowered sample which contributed 
to a lack of intervention effect. The delay between recruitment 
and enrolment to ensure the efficient use of interpreters 
added to attrition rates as potential participants lost interest in 
participating over time. The instruments used in this study may 
also not have been sensitive to CALD groups using interpreter 
services. Some participants indicated they could not see the 
point of answering the same set of questions repeatedly at each 
data collection point. An objective health measurement taken 
at each data collection point, such as blood pressure, may have 
improved the perceived relevance of the study for participants.
Strategies to overcome these difficulties include increasing the 
time allocated for recruitment and recruiting from additional 
sites, including primary care to achieve a powered sample 
size, and dedicated interpreters to assist with recruitment. 
Although the hospitals offered their own interpreters to assist 
with recruitment and had been briefed by the head of hospital 
interpreting services about the study, they were frequently 
busy and had limited availability to assist with recruitment. 
Importantly, recruitment needed to be followed by enrolment 
within a shorter period of time, with continuity of trained 
interpreters to keep participants engaged in the study and to 
obtain meaningful participant responses. Although written briefs 
were given to the agency outlining the interpreter’s role in the 
study, training was given while travelling to home visits or over 
the telephone.
Organising interpreter services was problematic when the 
intervention nurse and research assistants only spoke English 
and had no way of verifying communication between the 
interpreter, participant and family. Even when booking well 
in advance, cancellations were frequent, interpreters were 
unavailable, or even in another state (telephone contact), making 
continuity of interpreters extremely difficult. Employing 
bilingual researchers and research assistants would help to 
ensure participants received continuity of staff to allow 
familiarity and trust to develop and consistency of messages. 
However, we advertised for bilingual research staff but were 
unsuccessful at this time, and at the time of the study, there were 
two interpreting services in Melbourne who did not employ 
permanent interpreter staff for this type of work.
The role of agency interpreters lacked clarity, where some 
interpreters saw reminders and booking participants for 
data collection as clerical work rather than interpreter work, 
preferring other work, such as court and government jobs. 
Data collection was complicated by interpreters not agreeing to 
enter participants’ answers to surveys on hard copy. Instead, after 
the research assistant asked the interpreter to ask the question 
in the participant’s language, interpreters then translated the 
participant’s answer back to English for the research assistant 
to fill in. This made it difficult to obtain meaningful responses, 
increased participant burden, and increased the likelihood of 
missing important data and nuances to avert attrition.
The use of interpreters as peer leaders with these chronic 
conditions that were fully trained may have reduced attrition 
rates. Swerissen et al.’s (2006) research in Melbourne, Australia, 
which tested a peer-led, chronic disease self-management 
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programme in people from Vietnamese, Chinese, Italian and 
Greek backgrounds with one chronic condition, increased 
the time allocated for recruitment and the catchment area 
to obtain the required sample. However, this research also 
experienced high withdrawal rates (35%). The systematic review 
of interventions (Manias & Williams, 2010) for improving 
adherence in CALD groups showed the importance of bilingual 
language support and attention to cultural issues. Although the 
intervention was translated and interpreters were used, cultural 
sensitivity may not have been adequate in this study.
The cost-effectiveness of nurse-led interventions is an important 
consideration. Studies involving CALD groups are expensive 
to conduct, in particular, studies involving more than one 
cultural group. The multifactorial intervention home visit took 
approximately one and one quarter hours, excluding follow-up 
motivational interviewing calls. Future studies may consider 
peer-led group sessions and mobile phone applications with 
language functionalities for more efficient ways of supporting 
medication self-management.
Despite the considerable limitations of this research, participants 
in the intervention group were mostly unaware of damage 
to their kidneys or the effect of high blood pressure on their 
kidneys which they have now been alerted to. Participants who 
received the intervention reported being satisfied with home 
visits, understanding their medications better using materials 
that had been translated into their language, enjoyed being more 
actively engaged with their self-management and being able to 
ask health questions out of a formal consultation.
In our study, participants had limited access to resources to help 
them understand their chronic conditions and medications 
to make optimal daily decisions about their self-management. 
Given that the participants had multiple chronic conditions 
and took more than nine medications a day, disease self-
management and medication safety for this group was at risk. 
Programmes teaching self-management skills are integral to 
high-quality primary care (Bodenheiner et al., 2003), and are 
inclusive of CALD groups. Our findings concur with previous 
research investigating self-management skills in CALD groups in 
Melbourne (Swerissen et al., 2006; Walker et al. 2005; Williams 
et al., 2008). Lorig et al. (2005) tested a generic chronic disease 
self-management programme in 445 Spanish participants (two 
thirds with diabetes) in the US and Mexico which showed 
improvement in self-efficacy with significantly improved one-
year outcomes. However, participants in our study came from 
three different ethnic backgrounds and had multiple chronic 
conditions that increased the complexity of disease self-
management.
This study has shown that it is difficult to recruit and keep an 
older group of people who do not speak English with these 
key chronic conditions involved in research. The sample of 
participants in this study were mostly men aged 74 years of 
age who had been living in Australia for more than 40 years, 
yet most did not speak English well or not at all. A high 
proportion of this group had a low level of education, which 
may have been a major contributor to the attrition rate, lack 
of understanding of the study and a poor understanding of 
their disease and medications. The participants’ reluctance to 
participate in research which may be related to the many years 
they had been managing their diabetes and other chronic 
conditions independently, and being unaware of their kidney 
damage. Additionally, the urge to give back to society by way of 
participating may not have been a compelling factor for these 
people who came to Australia with few resources and supports 
to help them. It may be the case that targeting a younger 
group of CALD people in earlier stages of these disease states 
responsive to current immigration patterns has the potential for 
successful outcomes.
Implications for practice
The widening inequalities in access to health care are evidenced 
by health programmes not reaching those who would benefit 
most. CALD people with CKD, diabetes and CVD are in 
need of interventions for optimal health outcomes, taking into 
account the problems encountered in this pilot study. It was 
concerning that 14 participants were not aware that they had 
kidney trouble even though they were attending a nephrology 
clinic. We found a similar finding in our pilot work involving 
English-speaking participants with diabetes and kidney 
disease (Williams et al., 2008), indicative of the importance of 
clear communication in the management of complex health 
conditions. Strategies to improve medication self-efficacy 
in CALD groups include an increased use of interpreters in 
consultations, longer consultation times, the use of health 
professional staff who speak the same language, information 
regarding medications provided in the participants’ language, and 
regular review of all of the consumer’s medications, including 
medications that they have been on for some time.
Future research on CALD groups needs to implement strategies 
to enhance recruitment and retention to adequately engage 
participants, including extensive training of interpreters 
dedicated to the project. From an ethical perspective, it may 
have been appropriate to cease the study immediately after the 
intervention so as not to burden the remaining participants 
with data collection. This option was considered but we decided 
to complete the study so as not to waste resources and effort 
already spent.
Conclusion
Helping individuals to take their medications is central to 
the nurses’ role in order to serve and protect the wellbeing of 
multicultural communities. This work has highlighted difficulties 
with conducting research into CALD groups using interpreting 
services and communication gaps between health professionals 
and consumers affecting medication self-management. Although 
the intervention showed no effect, our results and experiences 
in conducting the study is important for the conduct of future 
research in CALD groups responsive to immigration patterns 
and disease prevalence.
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